Back to top
more

IDEXX Laboratories (IDXX)

(Real Time Quote from BATS)

$415.10 USD

415.10
198,019

-8.55 (-2.02%)

Updated Nov 15, 2024 11:46 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 26% (65 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Baxter (BAX) Hits a 52-Week High: What's Driving the Stock?

by Zacks Equity Research

Share price of Baxter International Inc. (BAX), a global medical technology company, rallied to a new 52-week high of $51.43 on Mar 8, eventually closing a bit lower at $51.36.

    Intersect ENT: FDA Submission of RESOLVE Implant, Stock Up

    by Zacks Equity Research

    Intersect ENT, Inc (XENT) recently announced the submission of a New Drug Application (NDA) approval with the U.S. FDA for reviewing its investigational RESOLVE steroid releasing implant.

      OPKO Health (OPK) Launches Prenatal Testing Tool ClariTest

      by Zacks Equity Research

      OPKO Health Inc. (OPK) recently announced the launch of a non-invasive medical test to detect fetal abnormalities.

        Meridian (VIVO) to Provide LeadCare Testing System in Africa

        by Zacks Equity Research

        Meridian Bioscience, Inc. (VIVO), a renowned life sciences company, recently signed an exclusive distribution agreement with Biofirm Technologies.

          TransEnterix (TRXC) Reports Wider-Than-Expected Loss in Q4

          by Zacks Equity Research

          TransEnterix, Inc. (TRXC) reported a loss of 12 cents per share in the fourth quarter of 2016, wider than the Zacks Consensus Estimate of a loss of 11 cents.

            Masimo Announces Availability of RD SedLine Brain Sensors

            by Zacks Equity Research

            Masimo Corporation (MASI) recently announced the availability of the RD SedLine EEG sensor, which can be used with the company???s flagship SedLine Brain Function Monitoring technology.

              Allscripts (MDRX) Acknowledged by LPP's CDIS Framework

              by Zacks Equity Research

              Allscripts Healthcare Solutions, Inc. (MDRX) recently announced that it has been accepted and acknowledged by the NHS London Procurement Partnership (LPP) in its Clinical and Digital Information Systems (CDIS) Framework.

                IDEXX (IDXX) Up 5.8% Since Earnings Report: Can It Continue?

                by Zacks Equity Research

                IDEXX (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                  Top Ranked Momentum Stocks to Buy for February 14th

                  by Zacks Equity Research

                  Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, February 14th:

                    Can the Rally in IDEXX Laboratories (IDXX) Shares Continue?

                    by Zacks Equity Research

                    IDEXX Laboratories, Inc. (IDXX) has been on the move lately as the stock has risen by 16.5% in the past four weeks, and it is currently trading well above its 20-Day SMA

                      Looking for a Growth Stock? Why It is Time to Focus on IDEXX Laboratories (IDXX)

                      by Zacks Equity Research

                      IDEXX Laboratories (IDXX) is seeing solid earnings estimate revision and has a favorable Zacks rank, making it well positioned for future earnings growth.

                        IDEXX Laboratories (IDXX) Q4 Earnings Rise; Tweaks View

                        by Zacks Equity Research

                        IDEXX Laboratories Inc. (IDXX) recorded fourth-quarter 2016 earnings per share (EPS) of 58 cents, up 21% year over year on a reported basis.

                          IDEXX Laboratories (IDXX) Beats Q4 Revenues, Y/Y EPS rises

                          by Zacks Equity Research

                          IDEXX Laboratories (IDXX) has seen growth in earnings year over year and has beaten the Zacks Consesnus Estimate in terms of revenue.

                            Medical Product Earnings Due on Feb 2: BDX, BSX, IDXX, ATHN

                            by Zacks Equity Research

                            The medical sector is likely to see 2.9% earnings growth on 5.7% higher revenues in the quarter.

                              IDEXX Laboratories (IDXX) Q4 Earnings: What's in Store?

                              by Zacks Equity Research

                              IDEXX Laboratories, Inc. (IDXX) is slated to report fourth-quarter 2016 results on Feb 2, before the opening bell.

                                IDEXX Laboratories (IDXX) Set to Join the S&P 500 Index

                                by Zacks Equity Research

                                IDEXX Laboratories, Inc. (IDXX) is scheduled to join the coveted S&P 500 benchmark, after the market closes on Jan 4.

                                  Neogen (NEOG) Acquires Brazilian Private Company Rogama

                                  by Zacks Equity Research

                                  Neogen Corporation (NEOG) announced that it has acquired Brazil-based Rogama Industria e Comercio Ltda.

                                    Patterson and ADPI Extend Partnership for Dental Platform

                                    by Zacks Equity Research

                                    Patterson Companies Inc. (PDCO), a leading distributor and seller of dental and animal health products, announced that it has extended its partnership with American Dental Partners or ADPI.

                                      Mazor Robotics Receives Order for Three Mazor X Systems

                                      by Zacks Equity Research

                                      Israel-based developer of robotic technology and products, Mazor Robotics Ltd. (MZOR), recently announced a three-system order for the Mazor X, from a leading mid-Atlantic health care organization.

                                        Cardinal Health to Pay $44M as Civil Penalty Settlement

                                        by Zacks Equity Research

                                        Cardinal Health Inc. (CAH) announced that it would shell out $44 million as civil penalties for a 2012 administrative settlement with the U.S. Drug Enforcement Agency or DEA.

                                          Varian to Acquire PerkinElmer's Medical Imaging Business

                                          by Zacks Equity Research

                                          Varian Medical Systems, Inc. (VAR) recently announced an agreement to takeover the Medical Imaging business of Waltham, MA-based PerkinElmer, Inc. (PKI) for $276 million.

                                            DaVita Ties Up With WellHealth, Expands in Southern Nevada

                                            by Zacks Equity Research

                                            DaVita HealthCare Partners Inc. (DVA), a leading provider of dialysis services, announced that HealthCare Partners Nevada, a unit within its medical group, has acquired WellHealth Quality Care.

                                              Fluidigm Unveils High-Throughput Integrated Fluidic Circuit

                                              by Zacks Equity Research

                                              Fluidigm Corporation (FLDM), a leading player in the analysis of single cells and industrial application of genomics, recently unveiled a new high-throughput integrated fluidic circuit (HT IFC) to separate single cells during mRNA sequencing analysis.

                                                WebMD Health (WBMD) Repurchaces 2 Million Common Shares

                                                by Zacks Equity Research

                                                WebMD Health Corp. (WBMD) announced that it has completed a tender offer to purchase 2 million shares of its common stock.

                                                  Accuray: Hong Kong Sanatorium to Buy 3 Radixact Systems

                                                  by Zacks Equity Research

                                                  Accuray Incorporated (ARAY) has signed an agreement with Hong Kong Sanatorium & Hospital per which the latter would purchase three Radixact Systems.